• Account Access
  • Contact Us

    Advisor Sales Support

    Mutual Funds and ETFs - 800-456-7526
    Monday-Thursday: 8:00 a.m. – 6:00 p.m. ET
    Friday: 8:00 a.m. – 5:00 p.m. ET

    ETF Trading Support - 415-315-6600
    Monday-Friday: 9:30 a.m. – 5:00 p.m. ET

    Investor & Website Support
    Monday-Friday: 9:00 a.m. - 6:00 p.m. ET

  • Advisor Log In

Hartford Healthcare Fund

Explore Another ETFs


Seeks long-term capital appreciation.


A stock fund that invests exclusively in health care, a sector that is experiencing innovations and breakthroughs across multiple subsectors.

More About Healthcare Fund 

The Health-Care Revolution

The health-care sector is undergoing dramatic changes that will impact everything from the drugs we take to the way patients’ medical records are shared. Aging demographics globally and rising prosperity in emerging-market nations will drive even greater demand for lifesaving drugs, innovative procedures, and disruptive medical technology.

Pipeline to Innovation

With innovation and breakthroughs taking place across the globe, the Fund uses a broadly diversified, global approach that seeks to identify companies with the greatest opportunities in areas including biotechnology, medical technology, health services, and pharmaceuticals.

Backed by Size, Scale, and Experience

Wellington Management, the Fund’s sub-adviser, is one of the largest managers of health care stocks in the world. The portfolio managers on the Fund average 26 years of experience.

Jean M. Hynes, CFA
Senior Managing Director
Global Industry Analyst
Ann C. Gallo
Senior Managing Director
Global Industry Analyst
Robert L. Deresiewicz
Senior Managing Director
Global Industry Analyst

Portfolio managers are supported by the full resources of Wellington Management.


Performance (%)
% (as of 8/31/2018)
Average Annual Total Returns % (as of 8/31/2018)
Hartford Healthcare  I 15.22 13.81 9.53 16.53 13.56 12.22
Benchmark 14.98 18.16 12.33 16.03 13.63 ---
Morningstar Health Category 18.82 21.05 9.17 15.87 13.99 ---
Performance (%)
% (as of 6/30/2018)
Average Annual Total Returns % (as of 6/30/2018)
Hartford Healthcare  I 5.49 5.53 4.94 15.78 13.32 11.79
Benchmark 3.28 8.60 6.49 14.38 13.20 ---
Morningstar Health Category 7.72 12.99 3.79 15.17 13.65 ---
SI = Since Inception. Fund Inception: 05/01/2000
Operating Expenses:   Net  1.03% |  Gross  1.03%

Share Class Inception: 8/31/06.
Class I-share performance prior to its inception date reflects Class A-share performance (excluding sales charges) and operating expenses. SI performance is calculated from 5/1/00.

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.

Growth of $10,000

(as of 8/31/2018)

Growth of $10,000

Reflects Class A, excluding sales charges. If sales charges and taxes had been included, the value would have been lower. Results for other classes will vary.


Morningstar Analyst Rating


Morningstar awarded the Fund a Bronze analyst rating on 4/3/181

Calendar Year Returns (%)
Fund Benchmark
2017 21.94 22.47
2016 -8.33 -2.05
2015 12.97 7.41
2014 26.80 24.79
2013 49.95 42.19
2012 20.14 18.35
2011 8.03 11.88
2010 6.69 5.20
2009 21.74 20.76
2008 -25.27 -23.76

Excludes sales charges. If sales charges and taxes had been included, the value would have been lower.

Characteristics Holdings are subject to change. Percentages may be rounded.

As of Date 8/31/2018
Net Assets $1.5 billion
# of Holdings 108
Beta 1.13
R Squared 0.88
% in Equities 96%
Turnover (6/30/2018) 21%
% in Foreign Equities 11%
Standard Deviation 15.26%
Holdings Characteristics
(as of 8/31/2018)
Fund S&P Composite 1500 Health Care Index
Asset Weighted Market Cap $56.4 billion $122.8 billion
EPS Growth Rate 17.3% 10.6%
Median Market Cap $5.2 billion $5.3 billion
Price/Book 4.9x 4.7x
Price/Earnings 51.5x 16.4x
Return on Equity -2.8% 20.9%
Return Characteristics
(as of 8/31/2018)
Alpha -1.10
Down Capture 113.32
Information Ratio 0.11
Sharpe Ratio 1.14
Up Capture 110.06
Market Cap Distribution %
(as of 08/31/2018)
Less than $2 billion 12.9
$2 billion - $5 billion 9.0
$5 billion - $10 billion 9.7
Greater than $10 billion 68.4

Top Ten Holdings (%)

(as of 8/31/2018)
label percentageholding
UnitedHealth Group, Inc. 6.19
Medtronic plc 3.88
Bristol-Myers Squibb Co. 3.72
Abbott Laboratories 3.57
Allergan plc 3.20
Boston Scientific Corp. 3.19
Eli Lilly & Co. 2.83
Thermo Fisher Scientific, Inc. 2.75
Anthem, Inc. 2.48
HCA Healthcare, Inc. 2.40
Total Portfolio % 34.21
(as of 6/30/2018)
label percentageholding
UnitedHealth Group, Inc. 6.24
Medtronic plc 4.40
Bristol-Myers Squibb Co. 3.75
Boston Scientific Corp. 3.24
Allergan plc 3.07
Stryker Corp. 2.71
Loxo Oncology, Inc. 2.66
Thermo Fisher Scientific, Inc. 2.58
Eli Lilly & Co. 2.52
AstraZeneca plc 2.24
Total Portfolio % 33.41
Fund Essentials
Inception Date 05/01/2000
Symbol HGHIX
CUSIP 416649887
Fund Number 1309

Subsector Exposure

(as of 8/31/2018)
label currentpercentage
Biopharma Mid Cap 22%
Biopharma Small Cap 12%
Health Care Services 23%
Medical Technology 24%
Biopharma Large Cap 20%
(as of 6/30/2018)
label currentpercentage
Biopharma Mid Cap 20%
Biopharma Small Cap 12%
Health Care Services 22%
Medical Technology 27%
Biopharma Large Cap 19%

Based on sub-adviser’s classification of health care subsectors, which includes combining biotechnology and pharmaceuticals in terms of capitalization: biopharma small-cap, biopharma mid-cap, and biopharma large-cap.  Excludes cash. May not total to 100% due to rounding.



The 5-Minute Forecast 3Q18 

Wed Jul 18 11:24:00 EDT 2018
A concise summary of the Hartford Funds Multi-Asset Team’s views on the main challenges facing investors: Growth, Income, Volatility, Inflation, and Taxes.

Client Conversations: HSAs: 1 Account, 3 Tax Benefits 

Thu Feb 15 12:00:00 EST 2018
Have a health savings account, but not contributing to it? You could be missing out.

Client Conversations: Why You Should Care About Medicare 

Fri Oct 13 12:00:00 EDT 2017
Medicare can be tough to understand. It doesn’t have to be.


Fund Literature

Select All

Fact Sheet

06/30/2018 | pdf
Get FINRA Letter

Max 100

Fund Story

06/30/2018 | pdf
Get FINRA Letter

Max 100


06/30/2018 | pdf
Get FINRA Letter

Max 100

Expanded Commentary

06/30/2018 | pdf

Max 100

Summary Prospectus

03/01/2018 | pdf

Available For
Download Only


06/30/2018 | pdf

Available For
Download Only

Semi Annual Report

04/30/2018 | pdf

Available For
Download Only

Statutory Prospectus

03/01/2018 | pdf

Available For
Download Only

Annual Report

10/31/2017 | pdf

Available For
Download Only


03/01/2018 | pdf

Available For
Download Only

Financial Professionals:

Log in to order forms and literature and manage your subscriptions.


Investing involves risk, including the possible loss of principal. There is no guarantee a fund will achieve its stated objective. Security prices fluctuate in value depending on general market and economic conditions and the prospects of individual companies. Risks of focusing investments on the healthcare related sector include regulatory and legal developments, patent considerations, intense competitive pressures, rapid technological changes, potential product obsolescence, and liquidity risk. Foreign investments may be more volatile and less liquid than U.S. investments and are subject to the risk of currency fluctuations and adverse political and economic developments. These risks may be greater for investments in emerging markets. Small- and mid-cap securities can have greater risks and volatility than large-cap securities.

1 The Morningstar Analyst Rating is not a credit or risk rating. It is a subjective evaluation performed by the manager research analysts of Morningstar. Morningstar evaluates funds based on five key pillars, which are process, performance, people, parent, and price. Analysts use this five pillar evaluation to determine how they believe funds are likely to perform over the long term on a risk-adjusted basis. They consider quantitative and qualitative factors in their research, and the weighting of each pillar may vary. The Analyst Rating scale is Gold, Silver, Bronze, Neutral, Negative. A Morningstar Analyst Rating of Gold, Silver, or Bronze reflects an Analyst’s conviction in a fund’s prospects for outperformance. Analyst Ratings are continuously monitored and reevaluated at least every 14 months. The Morningstar Analyst Rating should not be used as the sole basis in evaluating a mutual fund. Morningstar Analyst Ratings involve unknown risks and uncertainties which may cause Morningstar’s expectations not to occur or to differ significantly from what we expected. For more detailed information about Morningstar’s Analyst rating, including its methodology, please go to

© 2018 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/ or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.